Bronchiolitis and Bronchiolar Disorders

Abstract

Bronchioles are noncartilaginous small airways with internal diameter of 2 mm or less, located from approximately the eighth generation of purely air conducting airways (membranous bronchioles) down to the terminal bronchioles (the smallest airways without alveoli) and respiratory bronchioles (which communicate directly with alveolar ducts and are in the range of 0.5 mm or less in diameter). Bronchiolar injury, inflammation, and fibrosis may occur in myriad disorders including connective tissue diseases, inflammatory bowel diseases, lung transplant allograft rejection, graft versus host disease in allogeneic stem cell recipients, neuroendocrine cell hyperplasia, infections, drug toxicity (e.g., penicillamine, busulfan), inhalation injury (e.g., cigarette smoke, nylon flock, mineral dusts, hard metals, Sauropus androgynous); idiopathic, common variable immunodeficiency disorder, and a host of other disorders or insults. The spectrum of bronchiolar disorders is wide, ranging from asymptomatic to fatal obliterative bronchiolitis. In this review, we discuss the salient clinical, radiographic, and histological features of these diverse bronchiolar disorders, and discuss a management approach.

Keywords

bronchiolitis - small airways - cellular bronchiolitis - constrictive bronchiolitis - follicular bronchiolitis - lymphocytic bronchiolitis - cryptogenic organizing pneumonia

• References

• 1 Colby TV. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109 (01) 101-109
• 2 Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993; 14 (04) 611-622
• 3 Liptzin DR, DeBoer EM, Giller RH, Kroehl ME, Weinman JP. Evaluating for bronchiolitis obliterans with low-attenuation computed tomography three-dimensional reconstructions. Am J Respir Crit Care Med 2018; 197 (06) 814-815
• 4 Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003; 168 (11) 1277-1292
• 5 Wright JL, Cagle P, Churg A, Colby TV, Myers J. Diseases of the small airways. Am Rev Respir Dis 1992; 146 (01) 240-262
• 6 Garg K, Lynch DA, Newell JD, King Jr TE. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol 1994; 162 (04) 803-808
• 7 Poletti V, Casoni GL, Zompatori M, Carloni A, Cancellieri A, Chilosi M. Bronchiolitis. Eur Respir Mon 2011; 54: 84-103
• 8 Nicholson AG, Harris NL. Marginal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT type). In: Travis WD, Brambilla E, Muller-Hermelink HK. , et al., eds. Pathology and Genetics Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IACR Press; 2004: 88-90
• 9 Katzenstein A-LA. Miscellaneous II: nonspecific inflammatory and destructive diseases. In: Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. 4th ed. Philadelphia, PA: Elsevier; 2006: 445-476
• 10 Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83 (02) 161-162
• 11 King Jr TE. Overview of bronchiolitis. Clin Chest Med 1993; 14 (04) 607-610
• 12 Hansell DM. HRCT of obliterative bronchiolitis and other small airways diseases. Semin Roentgenol 2001; 36 (01) 51-65
• 13 Franquet T, Stern EJ. Bronchiolar inflammatory diseases: high-resolution CT findings with histologic correlation. Eur Radiol 1999; 9 (07) 1290-1303
• 14 Collins J, Blankenbaker D, Stern EJ. CT patterns of bronchiolar disease: what is “tree-in-bud”?. AJR Am J Roentgenol 1998; 171 (02) 365-370
• 15 Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol 2005; 185 (02) 354-363
• 16 Kligerman SJ, Henry T, Lin CT, Franks TJ, Galvin JR. Mosaic attenuation: etiology, methods of differentiation, and pitfalls. Radiographics 2015; 35 (05) 1360-1380
• 17 Sverzellati N, Zompatori M, Poletti V, Geddes DM, Hansell DM. Small chronic pneumothoraces and pulmonary parenchymal abnormalities after bone marrow transplantation. J Thorac Imaging 2007; 22 (03) 230-234
• 18 Gast KK, Biedermann A, Herweling A. , et al. Oxygen-sensitive 3He-MRI in bronchiolitis obliterans after lung transplantation. Eur Radiol 2008; 18 (03) 530-537
• 19 Burgel PR, Bergeron A, de Blic J. , et al. Small airways diseases, excluding asthma and COPD: an overview. Eur Respir Rev 2013; 22 (128) 131-147
• 20 Ravaglia C, Wells AU, Tomassetti S. , et al. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. BMC Pulm Med 2019; 19 (01) 16
• 21 Tomassetti S, Wells AU, Costabel U. , et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016; 193 (07) 745-752
• 22 Colella S, Ravaglia C, Massaccesi C. , et al. Does transbronchial lung cryobiopsy give useful information in asthmatic patients?. Multidiscip Respir Med 2019; 14: 12
• 23 Vasculitis. In: Cagle PT, Allen TC, Beasley MB. , eds. Diagnostic Pulmonary Pathology. 2nd ed. New York, NY: Informa; 2008
• 24 Ryu AJ, Navin PJ, Hu X, Yi ES, Hartman TE, Ryu JH. Clinico-radiologic features of lung disease associated with aspiration identified on lung biopsy. Chest 2019; 156 (06) 1160–1166
• 25 Arcadu A, Moua T, Yi ES, Ryu JH. Lymphoid interstitial pneumonia and other benign lymphoid disorders. Semin Respir Crit Care Med 2016; 37 (03) 406-420
• 26 Sirajuddin A, Raparia K, Lewis VA. , et al. Primary pulmonary lymphoid lesions: radiologic and pathologic findings. Radiographics 2016; 36 (01) 53-70
• 27 Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JD, Müller NL. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212 (03) 637-642
• 28 Aerni MR, Vassallo R, Myers JL, Lindell RM, Ryu JH. Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients. Respir Med 2008; 102 (02) 307-312
• 29 Tashtoush B, Okafor NC, Ramirez JF, Smolley L. Follicular bronchiolitis: a literature review. J Clin Diagn Res 2015; 9 (09) OE01-OE05
• 30 Ramirez-Sarmiento A, Orozco-Levi M, Walter EC, Au MA, Chien JW. Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant 2010; 16 (02) 199-206
• 31 Boag AH, Colby TV, Fraire AE. , et al. The pathology of interstitial lung disease in nylon flock workers. Am J Surg Pathol 1999; 23 (12) 1539-1545
• 32 Cordier J-F, Cottin V, Khouatra C. , et al. Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome. Eur Respir J 2013; 41 (05) 1126-1134
• 33 Poletti V. Eosinophilic bronchiolitis: is it a new syndrome?. Eur Respir J 2013; 41 (05) 1012-1013
• 34 Krefft SD, Cool CD, Rose CS. The emerging spectrum of exposure-related bronchiolitis. Curr Opin Allergy Clin Immunol 2018; 18 (02) 87-95
• 35 Lynch III JP, Weigt SS, DerHovanessian A, Fishbein MC, Gutierrez A, Belperio JA. Obliterative (constrictive) bronchiolitis. Semin Respir Crit Care Med 2012; 33 (05) 509-532
• 36 Lentz RJ, Fessel JP, Johnson JE, Maldonado F, Miller RF, Rickman OB. Transbronchial cryobiopsy can diagnose constrictive bronchiolitis in veterans of recent conflicts in the Middle East. Am J Respir Crit Care Med 2016; 193 (07) 806-808
• 37 Wight EC, Baqir M, Ryu JH. Constrictive bronchiolitis in patients with primary Sjögren syndrome. J Clin Rheumatol 2019; 25 (02) 74-77
• 38 Banks DE, Bolduc CA, Ali S, Morris MJ. Constrictive bronchiolitis attributable to inhalation of toxic agents: considerations for a case definition. J Occup Environ Med 2018; 60 (01) 90-96
• 39 Winningham PJ, Martínez-Jiménez S, Rosado-de-Christenson ML, Betancourt SL, Restrepo CS, Eraso A. Bronchiolitis: a practical approach for the general radiologist. Radiographics 2017; 37 (03) 777-794
• 40 Aguayo SM, Miller YE, Waldron Jr JA. , et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992; 327 (18) 1285-1288
• 41 Rice A, Nicholson AG. The pathologist's approach to small airways disease. Histopathology 2009; 54 (01) 117-133
• 42 Ryerson CJ, Olsen SR, Carlsten C. , et al. Fibrosing bronchiolitis evolving from infections or inhalational acute bronchiolitis. A reversible lesion. Ann Am Thorac Soc 2015; 12 (09) 1323-1327
• 43 Chilosi M, Poletti V, Murer B. , et al. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest 2002; 82 (10) 1335-1345
• 44 Kerr KM, Fraire AE. Atypical adenomatous hyperplasia. In: Cagle PT, Allen TC, Barrios R. , et al., eds. Color Atlas and Text of Pulmonary Pathology. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008: 132-125
• 45 Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 1967; 22 (03) 395-401
• 46 Evans DJ, Green M. Small airways: a time to revisit?. Thorax 1998; 53 (08) 629-630
• 47 Ryu JH, Scanlon PD. Obstructive lung diseases: COPD, asthma, and many imitators. Mayo Clin Proc 2001; 76 (11) 1144-1153
• 48 Eriksson G, Jarenbäck L, Peterson S, Ankerst J, Bjermer L, Tufvesson E. A new approach to assess COPD by identifying lung function break-points. Int J Chron Obstruct Pulmon Dis 2015; 10: 2193-2202
• 49 Piorunek T, Kostrzewska M, Stelmach-Mardas M. , et al. Small airway obstruction in chronic obstructive pulmonary disease: potential parameters for early detection. Adv Exp Med Biol 2017; 980: 75-82
• 50 Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry: interpretation and practical applications. Chest 2014; 146 (03) 841-847
• 51 Desiraju K, Agrawal A. Impulse oscillometry: the state-of-art for lung function testing. Lung India 2016; 33 (04) 410-416
• 52 Janigan DT, Kilp T, Michael R, McCleave JJ. Bronchiolitis obliterans in a man who used his wood-burning stove to burn synthetic construction materials. CMAJ 1997; 156 (08) 1171-1173
• 53 Cheng TH, Ko FC, Chang JL, Wu KA. Bronchiolitis obliterans organizing pneumonia due to titanium nanoparticles in paint. Ann Thorac Surg 2012; 93 (02) 666-669
• 54 Mittal R, Gupta P, Chhabra SK. Occupational bronchiolitis induced by cotton dust exposure in a nonsmoker. Indian J Occup Environ Med 2016; 20 (02) 118-120
• 55 Nureki S, Miyazaki E, Nishio S, Ando M, Kumamoto T. Hard metal lung disease successfully treated with inhaled corticosteroids. Intern Med 2013; 52 (17) 1957-1961
• 56 Poletti V, Chilosi M, Zompatori M. Bronchiolitis. In: Gibson GJ, Geddes DM, Costabel U. , et al., eds. Respiratory Medicine. Vol. 2. Philadelphia, PA: Saunders; 2003: 1526-1539
• 57 King MS, Eisenberg R, Newman JH. , et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med 2011; 365 (03) 222-230
• 58 Dhoma S, Gottschall B, Robinson M. , et al. Lung disease in deployers returning from Afghanistan and Iraq. In: B106 Occupational and Environmental Determinants of Lung Function. 2013: A3669
• 59 Zwemer Jr FL, Pratt DS, May JJ. Silo filler's disease in New York State. Am Rev Respir Dis 1992; 146 (03) 650-653
• 60 Wu M, Gordon RE, Herbert R. , et al. Case report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ Health Perspect 2010; 118 (04) 499-504
• 61 de la Hoz RE. Occupational lower airway disease in relation to World Trade Center inhalation exposure. Curr Opin Allergy Clin Immunol 2011; 11 (02) 97-102
• 62 Guidotti TL, Prezant D, de la Hoz RE, Miller A. The evolving spectrum of pulmonary disease in responders to the World Trade Center tragedy. Am J Ind Med 2011; 54 (09) 649-660
• 63 Mann JM, Sha KK, Kline G, Breuer FU, Miller A. World Trade Center dyspnea: bronchiolitis obliterans with functional improvement: a case report. Am J Ind Med 2005; 48 (03) 225-229
• 64 Cummings KJ, Stanton ML, Nett RJ. , et al. Severe lung disease characterized by lymphocytic bronchiolitis, alveolar ductitis, and emphysema (BADE) in industrial machine-manufacturing workers. Am J Ind Med 2019; 62 (11) 927-937
• 65 Ghanei M, Abolmaali K, Aslani J. Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: an open-label study. Curr Ther Res Clin Exp 2004; 65 (06) 495-504
• 66 Abtahi H, Peiman S, Foroumandi M, Safavi E. Long term follow-up of sulfur mustard related bronchiolitis obliterans treatment. Acta Med Iran 2016; 54 (09) 605-609
• 67 Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002; 347 (05) 330-338
• 68 Churg A, Wright JL. Airway wall remodeling induced by occupational mineral dusts and air pollutant particles. Chest 2002; 122 (6, Suppl): 306S-309S
• 69 Delpierre S, Delvolgo-Gori MJ, Faucher M, Jammes Y. High prevalence of reversible airway obstruction in asbestos-exposed workers. Arch Environ Health 2002; 57 (05) 441-445
• 70 Adelroth E, Hedlund U, Blomberg A. , et al. Airway inflammation in iron ore miners exposed to dust and diesel exhaust. Eur Respir J 2006; 27 (04) 714-719
• 71 Oliver LC, Miracle-McMahill H. Airway disease in highway and tunnel construction workers exposed to silica. Am J Ind Med 2006; 49 (12) 983-996
• 72 Kreiss K. Occupational bronchiolitis obliterans masquerading as COPD. Am J Respir Crit Care Med 2007; 176 (05) 427-429
• 73 Penn CC, Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993; 14 (04) 645-654
• 74 Esposito AJ, Chu SG, Madan R, Doyle TJ, Dellaripa PF. Thoracic manifestations of rheumatoid arthritis. Clin Chest Med 2019; 40 (03) 545-560
• 75 Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjögren's syndrome. Eur Respir Rev 2016; 25 (140) 110-123
• 76 Jatwani S, Handa R, Jatwani K, Chugh K. Bronchiolitis obliterans organising pneumonia as an initial manifestation in a patient with systemic lupus erythematosus: a rare presentation. BMJ Case Rep 2018; 2018: 2018
• 77 Chung A, Wilgus ML, Fishbein G, Lynch III JP. Pulmonary and bronchiolar involvement in Sjogren's syndrome. Semin Respir Crit Care Med 2019; 40 (02) 235-254
• 78 Mori S, Koga Y, Sugimoto M. Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol 2011; 21 (02) 164-173
• 79 Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998; 157 (5 Pt 1): 1658-1665
• 80 Nadeem I, Kennedy MP. Bronchiolitis obliterans without joint disease. A rare non-articular manifestation of rheumatoid arthritis. Ir Med J 2018; 111 (08) 813
• 81 Tanaka N, Kim JS, Newell JD. , et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232 (01) 81-91
• 82 Homma S, Kawabata M, Kishi K. , et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 1998; 12 (02) 444-452
• 83 Ito I, Nagai S, Kitaichi M. , et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005; 171 (06) 632-638
• 84 Puéchal X, Bienvenu T, Génin E. , et al. Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritis. Ann Rheum Dis 2011; 70 (04) 653-659
• 85 Puéchal X, Fajac I, Bienvenu T. , et al. Increased frequency of cystic fibrosis deltaF508 mutation in bronchiectasis associated with rheumatoid arthritis. Eur Respir J 1999; 13 (06) 1281-1287
• 86 Ohe M, Shida H, Horita T. , et al. Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisolone. Drug Discov Ther 2017; 11 (04) 218-222
• 87 Meijer JM, Pijpe J, Vissink A, Kallenberg CG, Bootsma H. Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Ann Rheum Dis 2009; 68 (02) 284-285
• 88 Silva BRA, Rufino R, Costa CH, Vilela VS, Levy RA, Lopes AJ. Ventilation distribution and small airway function in patients with systemic sclerosis. Rev Port Pneumol (2006) 2017; 23 (03) 132-138
• 89 Bonifazi M, Sverzellati N, Negri E. , et al. Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry. Rheumatology (Oxford) 2019 (e-pub ahead of print). Doi: 10.1093/rheumatology/kez340
• 90 Estenne M, Maurer JR, Boehler A. , et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21 (03) 297-310
• 91 Verleden SE, McDonough JE, Schoemans H. , et al. Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation. Mod Pathol 2019; 32 (06) 817-829
• 92 Welsh CH, Wang TS, Lyu DM. , et al; The American Thoracic Society Implementation Task Force. An international ISHLT/ATS/ERS clinical practice guideline: summary for clinicians. Bronchiolitis obliterans syndrome complicating lung transplantation. Ann Am Thorac Soc 2015; 12 (01) 118-119
• 93 Dettmer S, Suhling H, Klingenberg I. , et al. Lobe-wise assessment of lung volume and density distribution in lung transplant patients and value for early detection of bronchiolitis obliterans syndrome. Eur J Radiol 2018; 106: 137-144
• 94 Duque-Afonso J, Ihorst G, Waterhouse M. , et al. Impact of lung function on bronchiolitis obliterans syndrome and outcome after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning. Biol Blood Marrow Transplant 2018; 24 (11) 2277-2284
• 95 Finlen Copeland CA, Snyder LD, Zaas DW, Turbyfill WJ, Davis WA, Palmer SM. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010; 182 (06) 784-789
• 96 Van Herck A, Verleden SE, Sacreas A. , et al. Validation of a post-transplant chronic lung allograft dysfunction classification system. J Heart Lung Transplant 2019; 38 (02) 166-173
• 97 Müller C, Andersson-Sjöland A, Schultz HH. , et al. Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation. BMJ Open Respir Res 2017; 4 (01) e000177
• 98 Shah RJ, Diamond JM. Update in chronic lung allograft dysfunction. Clin Chest Med 2017; 38 (04) 677-692
• 99 Lama VN, Murray S, Mumford JA. , et al. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med 2005; 172 (03) 379-383
• 100 Vella S, Conaldi PG, Cova E. , et al. Lung resident mesenchymal cells isolated from patients with the bronchiolitis obliterans syndrome display a deregulated epigenetic profile. Sci Rep 2018; 8 (01) 11167
• 101 Hodge G, Hodge S, Yeo A. , et al. BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-Like, and NK cells in the small airways. Transplantation 2017; 101 (10) 2469-2476
• 102 Karnes HE, Schindler EI, Morrell M. , et al. Factors associated with mortality and response to extracorporeal photopheresis in lung allograft recipients with bronchiolitis obliterans syndrome. Transplantation 2019; 103 (05) 1036-1042
• 103 Yates B, Murphy DM, Forrest IA. , et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005; 172 (06) 772-775
• 104 DerHovanessian A, Wallace WD, Lynch III JP, Belperio JA, Weigt SS. Chronic lung allograft dysfunction: evolving concepts and therapies. Semin Respir Crit Care Med 2018; 39 (02) 155-171
• 105 Traxler D, Schweiger T, Schwarz S. , et al. The lymphatic phenotype of lung allografts in patients with bronchiolitis obliterans syndrome and restrictive allograft syndrome. Transplantation 2017; 101 (02) 310-315
• 106 Lendermon EA, Dodd-O JM, Coon TA. , et al. Azithromycin fails to prevent accelerated airway obliteration in T-bet^−/− mouse lung allograft recipients. Transplant Proc 2018; 50 (05) 1566-1574
• 107 Ren D, Kaleekal TS, Graviss EA. , et al. Retransplantation outcomes at a large lung transplantation program. Transplant Direct 2018; 4 (11) e404
• 108 Habre C, Soccal PM, Triponez F. , et al. Radiological findings of complications after lung transplantation. Insights Imaging 2018; 9 (05) 709-719
• 109 Gao F, Chen J, Wei D, Wu B, Zhou M. Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation. Front Med 2018; 12 (02) 224-228
• 110 Bergeron A, Cheng GS. Bronchiolitis obliterans syndrome and other late pulmonary complications after allogeneic hematopoietic stem cell transplantation. Clin Chest Med 2017; 38 (04) 607-621
• 111 Grønningsæter IS, Tsykunova G, Lilleeng K, Ahmed AB, Bruserud Ø, Reikvam H. Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment. Expert Rev Clin Immunol 2017; 13 (06) 553-569
• 112 Williams KM. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Blood 2017; 129 (04) 448-455
• 113 Norman BC, Jacobsohn DA, Williams KM. , et al. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplant 2011; 46 (10) 1369-1373
• 114 Koenecke C, Hertenstein B, Schetelig J. , et al. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. Am J Transplant 2010; 10 (08) 1897-1906
• 115 Keller CA, Gonwa TA, Hodge DO, Hei DJ, Centanni JM, Zubair AC. Feasibility, safety, and tolerance of mesenchymal stem cell therapy for obstructive chronic lung allograft dysfunction. Stem Cells Transl Med 2018; 7 (02) 161-167
• 116 Hefazi M, Langer KJ, Khera N. , et al. Extracorporeal photopheresis improves survival in hematopoietic cell transplant patients with bronchiolitis obliterans syndrome without significantly impacting measured pulmonary functions. Biol Blood Marrow Transplant 2018; 24 (09) 1906-1913
• 117 Bergeron A, Réa D, Levy V. , et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med 2007; 176 (08) 814-818
• 118 Janoski MM, Raymond GS, Puttagunta L, Man GC, Barrie JR. Psyllium aspiration causing bronchiolitis: radiographic, high-resolution CT, and pathologic findings. AJR Am J Roentgenol 2000; 174 (03) 799-801
• 119 El Ati Z, Lamia R, Cherif J. , et al. Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma. Saudi J Kidney Dis Transpl 2019; 30 (04) 974-977
• 120 Moeser A, Pletz MW, Hagel S, Kroegel C, Stallmach A. Lung disease and ulcerative colitis—mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?. Z Gastroenterol 2015; 53 (09) 1091-1098
• 121 Mukhopadhyay S, Katzenstein AL. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol 2007; 31 (05) 752-759
• 122 Wang JS, Tseng HH, Lai RS, Hsu HK, Ger LP. Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitis—-histopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression. Histopathology 2000; 37 (05) 402-410
• 123 Oonakahara K, Matsuyama W, Higashimoto I. , et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan—alert of food-associated pulmonary disorders from Japan. Respiration 2005; 72 (02) 221
• 124 Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000; 15 (01) 41-48
• 125 Papanikolaou I, Kagouridis K, Papiris SA. Patterns of airway involvement in inflammatory bowel diseases. World J Gastrointest Pathophysiol 2014; 5 (04) 560-569
• 126 Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. Eur Respir J 2006; 28 (04) 862-871
• 127 Keng LT, Lee MR. Diffuse panbronchiolitis. Postgrad Med J 2019; 95 (1121): 175
• 128 Brugiere O, Milleron B, Antoine M, Carette MF, Philippe C, Mayaud C. Diffuse panbronchiolitis in an Asian immigrant. Thorax 1996; 51 (10) 1065-1067
• 129 Poletti V, Patelli M, Poletti G, Bertanti T, Spiga L. Diffuse panbronchiolitis observed in an Italian. Chest 1990; 98 (02) 515-516
• 130 Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America. Report of three cases and review of the literature. Am J Surg Pathol 1991; 15 (01) 43-47
• 131 Homer RJ, Khoo L, Smith GJ. Diffuse panbronchiolitis in a Hispanic man with travel history to Japan. Chest 1995; 107 (04) 1176-1178
• 132 Fitzgerald JE, King Jr TE, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996; 154 (2 Pt 1): 497-503
• 133 Zompatori M, Poletti V. Diffuse panbronchiolitis. An Italian experience. Radiol Med (Torino) 1997; 94 (06) 680-682
• 134 Fisher Jr MS, Rush WL, Rosado-de-Christenson ML. , et al. Diffuse panbronchiolitis: histologic diagnosis in unsuspected cases involving North American residents of Asian descent. Arch Pathol Lab Med 1998; 122 (02) 156-160
• 135 Kamio K, Matsushita I, Hijikata M. , et al. Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis. Am J Respir Crit Care Med 2005; 171 (09) 949-957
• 136 Matsuura H, Yoshida Y, Yamaji Y. Diffuse panbronchiolitis. QJM 2017; 110 (04) 253
• 137 Kim JH, Jung KH, Han JH. , et al. Relation of epidermal growth factor receptor expression to mucus hypersecretion in diffuse panbronchiolitis. Chest 2004; 126 (03) 888-895
• 138 Weinberger M, Lesser D. Diffuse panbronchiolitis: a progressive fatal lung disease that is curable with azithromycin, but only if diagnosed!. Pediatr Pulmonol 2019; 54 (04) 457-462
• 139 Chuang MC, Chou YT, Lin YC, Hsieh MJ, Tsai YH. Diffuse panbronchiolitis—the response and recurrence after erythromycin therapy. J Formos Med Assoc 2016; 115 (10) 876-882
• 140 Weng D, Wu Q, Chen XQ. , et al. Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway. Biomed Pharmacother 2019; 110: 440-448
• 141 Xu B, Mao Y, Wan X. , et al. Prognostic value of concomitant bronchiectasis in newly diagnosed diffuse panbronchiolitis patients on a maintenance therapy with macrolides. Can Respir J 2019; 2019: 4913814
• 142 Sugimoto S, Miyoshi K, Yamane M, Oto T. Lung transplantation for diffuse panbronchiolitis: 5 cases from a single centre. Interact Cardiovasc Thorac Surg 2016; 22 (05) 679-681
• 143 Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291 (15) 755-758
• 144 Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54 (11) 1009-1014
• 145 Woo OH, Yong HS, Oh YW, Lee SY, Kim HK, Kang EY. Respiratory bronchiolitis-associated interstitial lung disease in a nonsmoker: radiologic and pathologic findings. AJR Am J Roentgenol 2007; 188 (05) W412-4
• 146 Turton CW, Williams G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981; 36 (11) 805-810
• 147 Kindt GC, Weiland JE, Davis WB, Gadek JE, Dorinsky PM. Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989; 140 (02) 483-492
• 148 Kraft M, Mortenson RL, Colby TV, Newman L, Waldron Jr JA, King Jr TE. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis 1993; 148 (4 Pt 1): 1093-1101
• 149 Nguyen VT, Ndoye A, Bassler KD. , et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001; 137 (02) 193-206
• 150 Nousari HC, Deterding R, Wojtczack H. , et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340 (18) 1406-1410
• 151 Hasegawa Y, Shimokata K, Ichiyama S, Saito H. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J 1999; 13 (04) 934-937
• 152 Maldonado F, Pittelkow MR, Ryu JH. Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome. Respirology 2009; 14 (01) 129-133
• 153 Davies SJ, Gosney JR, Hansell DM. , et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007; 62 (03) 248-252
• 154 Nassar AA, Jaroszewski DE, Helmers RA, Colby TV, Patel BM, Mookadam F. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am J Respir Crit Care Med 2011; 184 (01) 8-16
• 155 Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009; 145 (06) 709-727
• 156 Tashtoush B, Memarpour R, Ramirez J, Bejarano P, Mehta J. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency. Clin Respir J 2018; 12 (01) 337-343
• 157 Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol 2010; 134 (02) 97-103
• 158 Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114 (02) 415-421
• 159 Gregersen S, Aaløkken TM, Mynarek G. , et al. High resolution computed tomography and pulmonary function in common variable immunodeficiency. Respir Med 2009; 103 (06) 873-880
• 160 Davies CW, Juniper MC, Gray W, Gleeson FV, Chapel HM, Davies RJ. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 2000; 55 (01) 88-90
• 161 Hatab AZ, Ballas ZK. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 2005; 116 (05) 1161-1162
• 162 Ng J, Wright K, Alvarez M, Hunninghake GM, Wesemann DR. Rituximab monotherapy for common variable immune deficiency-associated granulomatous-lymphocytic interstitial lung disease. Chest 2019; 155 (05) e117-e121
• 163 Seccombe EL, Ardern-Jones M, Walker W. , et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Clin Exp Dermatol 2019; 44 (08) 897-902
• 164 Flora AS, Simo H, Assaly R. Increasing role of macrolide anti-inflammatory therapy in secondary organizing pneumonia. Am J Ther 2017; 24 (04) e495
• 165 Parto K, Svedström E, Majurin ML, Härkönen R, Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest 1993; 104 (04) 1176-1182
• 166 Ito M, Nakagawa A, Hirabayashi N, Asai J. Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch 1997; 430 (02) 131-137
• 167 Trisolini R, Lazzari Agli L, Poletti V. Bronchiolocentric pulmonary involvement due to chronic lymphocytic leukemia. Haematologica 2000; 85 (10) 1097
• 168 Churg A, Myers J, Suarez T. , et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 2004; 28 (01) 62-68
• 169 Yousem SA, Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod Pathol 2002; 15 (11) 1148-1153
• 170 Devakonda A, Raoof S, Sung A, Travis WD, Naidich D. Bronchiolar disorders: a clinical-radiological diagnostic algorithm. Chest 2010; 137 (04) 938-951